JIGARNING NOALKAGOL YOG’ XASTALIGIDA METABOLIK HOLATLARINI TASHXISLASHDA LABORATOR TEKSHIRUV NATIJALARINI AHAMIYATI

Authors

  • Xudoyberdiyeva Sh.I Author

Keywords:

Kalit so’zlar: laboratoriya diagnostikasi, jigarning noalkagol yog’ xastaligi (JNAYoX), steatohepatit, metformin, pioglitazon, jigaKalit so’zlar: laboratoriya diagnostikasi, jigarning noalkagol yog’ xastaligi (JNAYoX), steatohepatit, metformin, pioglitazon, jigar steatozi. r steatozi.

Abstract

Yog’li  gepatoz  murakkab  kasallik  bo’lib,  uning  rivojlanishi  ko’plab  omillar 
bilan bog’liq. Uning patogenezi metabolik kasalliklar, shuningdek, turli organlar va 
tizimlarning disfunktsiyasi bilan chambarchas bog’liq. Bundan tashqari, bu holat bir 
qator kasalliklar, jumladan, qon tomir aterosklerozning rivojlanishiga hamroh bo’lishi 
mumkin. 
Zamonaviy  ilmiy  tadqiqotlar  shuni  ko’rsatadiki,  jigarning  noalkagol  yog’ 
xastaligi  (JNAYoX) jiddiy  jigar  muammolarining ko’rsatkichi bo’lib xizmat  qilishi 
mumkin. Bundan tashqari, u diabet, lipid almashinuvining buzilishi yoki ortiqcha vazn 
mavjudligidan  qat’iy  nazar,  yurak-qon  tomir  kasalliklarining  rivojlanishi  uchun 
mustaqil xavf omili sifatida harakat qilishi mumkin. 
Ushbu  maqolada  yurak-qon  tomir  kasalliklari  bilan  og’rigan  odamlarda 
metabolik  bilan  bog’liq  jigarning  noalkagol  yog’  xastaligi  (JNAYoX)  tarqalishi, 
sabablari, rivojlanish mexanizmlari, diagnostikasi va klinik ko’rinishlariga oid ilmiy 
tadqiqotlar  tahlili.  Ushbu  mavzuning  muhimligini  hisobga  olib,  kelgusida  ushbu 
yo’nalishda olib boriladigan tadqiqotlarning yo’nalishlarini belgilash kerak. 

References

Foydalanilgan adabiyotlar:

1. Zokirov V. Z. COVID 19 o’tkazgan va o’tkazmagan jigarning noalkagol

yog’xastaligi bilan og’rigan bemorlar klinikasi va labarator tahlillarining

solishtirma tahlili //Scientific progress. – 2022. – Т. 3. – №. 1. – С. 670-675.

2. Zokirov V. Z. COMPARATIVE ANALYSIS OF THE RESULTS OF

LABORATORY-BIOCHEMICAL ANALYSIS IN MIDDLE-AGED AND

ELDERLY PATIENTS WITH NON-ALCOHOLIC FATTY LIVER

DISEASE AFTER COVID-19 //Art of Medicine. International Medical

Scientific Journal. – 2022. – Т. 2. – №. 1.

3. Yuldasheva D. H., Muxamedova Z. R., Zokirov V. Z. CHRONIC LIVER

DISEASE AND COVID-2019 (literature review and own data) //E-

Conference Globe. – 2021. – С. 193-197.

4. Yuldasheva D. H., Zokirov V. Z., Oltiboyev R. O. Modern approaches to the

pathogenesis of non-alcoholic fatty liver disease //Euro-Asia Conferences. –

2021. – С. 384-389.

5. Zokirov V. Z. Chronic liver disease and covid-2019 (literature review and

own data) //research journal of trauma and disability studies. – 2021. – Т. 1.

– С. 1-6.

6. Khamraev A. A. et al. Clinical-laboratory markers of progression of non-

alcoholic fatty liver disease //American Journal of Medicine and Medical Sciences. – 2021. – Т. 11. – №. 5. – С. 419-425.

7. Yuldasheva D. H. et al. Non-alcoholic Fatty Liver Disease Modern View Of

The Problem //JournalNX. – 2020. – Т. 6. – №. 12. – С. 286-292.

Published

2025-05-06

How to Cite

Xudoyberdiyeva Sh.I. (2025). JIGARNING NOALKAGOL YOG’ XASTALIGIDA METABOLIK HOLATLARINI TASHXISLASHDA LABORATOR TEKSHIRUV NATIJALARINI AHAMIYATI . TADQIQOTLAR, 61(4), 54-59. https://scientific-jl.com/tad/article/view/12198